Maryland, 23 Dec 2024: An FDA advisory panel vote of 9-1 to recommend the approval of Mesoblast Limited’s graft versus host disease (GVHD) cell therapy was a cruel tease for the Australian company.

 

More than four years later—and after two r......
View Details

Related News

• Sirsa: About 83 thousand 545 pills recovered from a house, accused arrested (16-01-2025)

---

• AI eBay algorithm blocks two million illegal medicine sales (16-01-2025)

---

• Sun Pharma unit Taro to acquire 100% stake in Antibe Therapeutics (16-01-2025)

---

• Calcutta HC directs Paschim Banga Pharmaceuticals to stop manufacturing; state to compensate families (16-01-2025)

---

• FDA Revokes Use of 'FD&C Red No.3' in Foods and Drugs (16-01-2025)

---

• Dabur sues Patanjali over toothpaste trade dress (16-01-2025)

---

• Wrappers of drug brands found from Paonta printing press premises (16-01-2025)

---

• PCI revises list of pharmacists blocked on DIGI-PHARMed platform, asks to re-register (16-01-2025)

---

• Clear labelling of industrial & medical oxygen must, PMO tells health ministry (16-01-2025)

---

• Himachal to form Special Task Force to Combat Drug Abuse (16-01-2025)

---